Health Care & Life Sciences » Pharmaceuticals | Assembly Biosciences Inc.

Assembly Biosciences Inc. | Key People and Executives

Derek A. Small
President, Chief Executive Officer & Director
Bill R. Ringo
Non-Executive Chairman
Helen Susan Kim
Independent Director
Susan Mahony
Independent Director
Alan J. Lewis
Independent Director
Richard D. DiMarchi
Independent Director
Anthony E. Altig
Independent Director
Myron Z. Holubiak
Independent Director
Mark Auerbach
Independent Director
Derek A. Small
President, Chief Executive Officer & Director
Graham K. Cooper
Chief Operating, Financial & Accounting Officer
Uri A. Lopatin
Chief Medical Officer, VP-Research & Development
Jackie Papkoff
Senior VP & Chief Scientific Officer-Microbiome
Richard J. Colonno
EVP & Chief Scientific Officer-Virology Operations
Wayne K. Herber
Senior Vice President-Biological Manufacturing
Thomas E. Rollins
Chief Development Officer
Micah Mackison
Vice President-Corporate Development & Strategy
Hong Mei Huang
VP-Information Technology & Informatics
J. P. Benya
Vice President-Business Development
Barbara Lindheim
Media Contact
Lauren Glaser
Investor Relations Contact
Jennifer A. Troia
Senior VP-HR & Organization Development
Elizabeth Haber Lacy
Secretary, General Counsel & VP-Legal Operations
Bill R. Ringo
Non-Executive Chairman
Helen Susan Kim
Independent Director
Susan Mahony
Independent Director
Alan J. Lewis
Independent Director
Richard D. DiMarchi
Independent Director
Anthony E. Altig
Independent Director
Myron Z. Holubiak
Independent Director
Mark Auerbach
Independent Director

About Assembly Biosciences

View Profile
Address
11711 North Meridian Street
Carmel Indiana 46032
United States
Employees -
Website http://www.assemblybio.com
Updated 07/08/2019
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.